Showing 21 - 40 results of 70 for search '"Merck ', query time: 0.05s Refine Results
  1. 21
  2. 22
  3. 23

    Establishing a new human pneumococcal standard reference serum, MPRSS-01 by Joseph M. Antonello, Rocio D. Murphy, Chitrananda Abeygunawardana, Juliana C. Malinverni, Rajam Gowrisankar, Tina Green, Rebecca Greway, Jenna Schmauch, Adrienne Howlett, Cyrille J. Bonhomme, Katrina M. Nolan

    Published 2025-01-01
    “…Antibody concentrations to 33 pneumococcal serotypes were assigned in a new Merck Pneumococcal Reference Serum Standard (MPRSS-01; Merck Pneumococcal Reference Serum Standard) using the pneumococcal electrochemiluminescence assay. …”
    Get full text
    Article
  4. 24
  5. 25
  6. 26
  7. 27
  8. 28
  9. 29
  10. 30
  11. 31
  12. 32
  13. 33

    Antibody Response in Seropositive Multiple Sclerosis Patients Vaccinated with Attenuated Live Varicella Zoster Virus by RT Ross, MR Dawood, Mary Cheang, Lindsay E Nicolle

    Published 1996-01-01
    “…OBJECTIVE: To determine the safety and effectiveness of live attenuated varicella zoster virus (VZV) vaccine (OKA/Merck) on 50 patients with chronic progressive multiple sclerosis (MS), based on the hypothesis that VZV might be the antigen or antigen mimic of MS plus the fact that repeated high antigen doses have produced ‘antigen paralysis’ in experimental allergic encephalomyelitis mice.…”
    Get full text
    Article
  14. 34
  15. 35
  16. 36
  17. 37

    Sugammadex-Associated Hypotension, Bradycardia, Asystole, and Death by Kazim Mirza, Kathryn Landoski, Dilip Thakar, Jagtar Heir-Singh, Timothy Jackson, Cynthia Kassab

    Published 2020-01-01
    “…On December 16, 2015, the Food and Drug Administration (FDA) in the United States approved sugammadex (Bridion, Merck and Co), a modified gamma-cyclodextrin, to be used as a reversal agent. …”
    Get full text
    Article
  18. 38

    Pharma TARP: A Troubled Asset Relief Program for Novel, Abandoned Projects in the Pharmaceutical Industry by Tamas Bartfai, Graham Vaughan Lees

    Published 2011-01-01
    “…Within days of each other, Pfizer, Merck, and GlaxoSmithKline announced that they will focus on a few therapeutic areas only and abandon others entirely. …”
    Get full text
    Article
  19. 39
  20. 40

    Uma auditoria confiável adiciona valor? by Ricardo D. Brito, Eduardo P. Peres

    Published 2006-01-01
    “…Examinamos especificamente o impacto no valor de mercado dos clientes das 5 Grandes, cobrindo eventos de 2002 nos quais os procedimentos de auditoria de uma delas e sua independência encontravam-se sob escrutínio: Omnicon, Merck, WorldCom, Qwest, Xerox, Bristol Meyers, Duke Energy, El Paso e AOL. …”
    Get full text
    Article